Gustavo Pérez-Nanclares

Gustavo Pérez-Nanclares

Auto-generated profile, based on publicly available information

Gustavo Pérez-Nanclares

Endocrinology and Diabetes Research Group, Hospital Universitario Cruces, BioCruces, CIBERER, CIBERDEM, UPV-EHU, Barakaldo, Basque Country, Spain

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2011 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
OBOihana Belar
Oihana Belar
CHCarmen De La Hoz
Carmen De La Hoz
GPGustavo Pérez-Nanclares
Gustavo Pérez-Nanclares
LCLuis Castaño
Luis Castaño
SGSonia Gaztambide
Sonia Gaztambide
SGSpanish MEN1 Group
Spanish MEN1 Group

14 October 2004 in Immunogenetics
Verified
Journal Article
Closed access
LOLourdes Ortiz
Lourdes Ortiz
JVJuan Carlos Vitoria
Juan Carlos Vitoria
IHIdoia Hualde
Idoia Hualde
RZRosa Zaballa
Rosa Zaballa
EPEnriqueta Preciado
Enriqueta Preciado
JBJose Ramon Bilbao
Jose Ramon Bilbao

20 November 2013 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
DEDonia Elhayek
Donia Elhayek
GNGustavo Perez de Nanclares
Gustavo Perez de Nanclares
SCSlaheddine Chouchane
Slaheddine Chouchane
SHSaber Hamami
Saber Hamami
AMAdnène Mlika
Adnène Mlika
GAGema Ariceta
Gema Ariceta
Background: Primary distal renal tubular acidosis (dRTA) caused by mutations in the genes that codify for the H + −ATPase pump subunits is a heterogeneous disease with a poor phenotype-genotype correlation. Up to now, large cohorts of dRTA Tunisian patients have not been analyzed, and molecular defects may differ from those described in other ethnicities. We aim to identify molecular defects present in the ATP6V1B1, ATP6V0A4 and SLC4A1 genes in a Tunisian cohort, according to the following algorithm: first, ATP6V1B1 gene analysis in dRTA patients with sensorineural hearing loss (SNHL) or unknown hearing status. Afterwards, ATP6V0A4 gene study in dRTA patients with normal hearing, and in those without any structural mutation in the ATP6V1B1 gene despite presenting SNHL. Finally, analysis of the SLC4A1 gene in those patients with a negative result for the previous studies. Methods: 25 children (19 boys) with dRTA from 20 families of Tunisian origin were studied. DNAs were extracted by the standard phenol/chloroform method. Molecular analysis was performed by PCR amplification and direct sequencing. Results: In the index cases, ATP6V1B1 gene screening resulted in a mutation detection rate of 81.25%, which increased up to 95% after ATP6V0A4 gene analysis. Three ATP6V1B1 mutations were observed: one frameshift mutation (c.1155dupC; p.Ile386fs), in exon 12; a G to C single nucleotide substitution, on the acceptor splicing site (c.175-1G > C; p.?) in intron 2, and one novel missense mutation (c.1102G > A; p.Glu368Lys), in exon 11. We also report four mutations in the ATP6V0A4 gene: one single nucleotide deletion in exon 13 (c.1221delG; p.Met408Cysfs*10); the nonsense c.16C > T; p.Arg6*, in exon 3; and the missense changes c.1739 T > C; p.Met580Thr, in exon 17 and c.2035G > T; p.Asp679Tyr, in exon 19. Conclusion: Molecular diagnosis of ATP6V1B1 and ATP6V0A4 genes was performed in a large Tunisian cohort with dRTA. We identified three different ATP6V1B1 and four different ATP6V0A4 mutations in 25 Tunisian children. One of them, c.1102G > A; p.Glu368Lys in the ATP6V1B1 gene, had not previously been described. Among deaf since childhood patients, 75% had the ATP6V1B1 gene c.1155dupC mutation in homozygosis. Based on the results, we propose a new diagnostic strategy to facilitate the genetic testing in North Africans with dRTA and SNHL.

26 April 2011 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
EFEduardo Fernández-Rebollo
Eduardo Fernández-Rebollo
GNGuiomar Perez de Nanclares
Guiomar Perez de Nanclares
BLBeatriz Lecumberri
Beatriz Lecumberri
STSerap Turan
Serap Turan
EAEmma Anda
Emma Anda
HJHarald Jüppner
Harald Jüppner
Most patients with autosomal dominant pseudohypoparathyroidism type Ib (AD‐PHP‐Ib) carry maternally inherited microdeletions upstream of GNAS that are associated with loss of methylation restricted to GNAS exon A/B. Only few AD‐PHP‐Ib patients carry microdeletions within GNAS that are associated with loss of all maternal methylation imprints. These epigenetic changes are often indistinguishable from those observed in patients affected by an apparently sporadic PHP‐Ib form that has not yet been defined genetically. We have now investigated six female patients affected by PHP‐Ib (four unrelated and two sisters) with complete or almost complete loss of GNAS methylation, whose healthy children (11 in total) showed no epigenetic changes at this locus. Analysis of several microsatellite markers throughout the 20q13 region made it unlikely that PHP‐Ib is caused in these patients by large deletions involving GNAS or by paternal uniparental isodisomy or heterodisomy of chromosome 20 (patUPD20). Microsatellite and single‐nucleotide variation (SNV) data revealed that the two affected sisters share their maternally inherited GNAS alleles with unaffected relatives that lack evidence for abnormal GNAS methylation, thus excluding linkage to this locus. Consistent with these findings, healthy children of two unrelated sporadic PHP‐Ib patients had inherited different maternal GNAS alleles, also arguing against linkage to this locus. Based on our data, it appears plausible that some forms of PHP‐Ib are caused by homozygous or compound heterozygous mutation(s) in an unknown gene involved in establishing or maintaining GNAS methylation. © 2011 American Society for Bone and Mineral Research

5 May 2005 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
JRJuan Rodríguez-Soriano
Juan Rodríguez-Soriano
AVAlfredo Vallo
Alfredo Vallo
GNGustavo Pérez de Nanclares
Gustavo Pérez de Nanclares
JBJose Ramon Bilbao
Jose Ramon Bilbao
LCLuis Castaño
Luis Castaño

1 August 2001 in Advances in Dental Research
Verified
Journal Article
Closed access
PDF file
FUF.J. Unda
F.J. Unda
AMA. Martín
A. Martín
CHC. Hernandez
C. Hernandez
GPG. Pérez-Nanclares
G. Pérez-Nanclares
EHE. Hilario
E. Hilario
JAJ. Aréchaga
J. Aréchaga
We have studied the expression of FGF1 and FGF2 during mouse odontogenesis by immunohistochemistry. FGF1 was detected in differentiated odontoblasts and at the secretory pole of ameloblasts. Localization of FGF2 was mainly observed within the basement membrane interposed between dental epithelium and dental mesenchyme. These findings indicate that FGF1 and FGF2 may participate in the control of odontoblast and ameloblast differentiation. Thereafter, we studied the ability of FGF1 and FGF2, alone or in combination with TGFβ1, to induce polarization and/or functional differentiation of pre-odontoblasts. Dental papillae (DP) obtained from first lower molars of 17-day-old mouse embryo were cultured in the presence or the absence of growth factors. DP cultured with FGFl+TGFβ1 showed gradients of odontoblast-like cell differentiation, which displayed alkaline phosphatase reactivity. DP treated with FGF2+TGFβ1 exhibited pre-odontoblast cell polarization, and the cell bodies displayed long cytoplasm processes. However, following this treatment we did not observe extracellular matrix secretion, and alkaline phosphatase activity was completely inhibited. In summary, our results show that exogenous addition of FGF1 to pre-odontoblasts induces their terminal differentiation, by synergistically acting with TGFβ1. In contrast, FGF2 may regulate the effect of TGFβ1, permitting cell polarization but restraining pre-odontoblast functions.